84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02265874 (ClinicalTrials.gov) | January 12, 2015 | 10/10/2014 | Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study | Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study | Sarcoidosis | Drug: Habitrol;Drug: Placebo to Habitrol | Ohio State University | The Cleveland Clinic | Completed | 18 Years | 75 Years | All | 57 | Phase 1/Phase 2 | United States |